Tetracosactide 250 Mcg

The core pathological mechanism of autoimmune and inflammatory diseases is immune dysfunction, in which the immune system mistakenly attacks the body's own tissues or organs, triggering persistent inflammation that can lead to tissue damage and organ dysfunction in severe cases. By stimulating endogenous cortisol secretion, tetracosactide 250 mcg avoids many adverse effects associated with direct exogenous glucocorticoid administration. It is particularly suitable for patients intolerant to oral glucocorticoids and has become an important alternative treatment for such diseases, with specific applications in the following conditions.

Crohn's Disease:Crohn's disease is a chronic, recurrent inflammatory bowel disease that can affect the entire thickness of the gastrointestinal tract. Clinical manifestations include abdominal pain, diarrhea, hematochezia, weight loss, and severely reduced quality of life. It is indicated for the acute phase of Crohn's disease, especially in patients intolerant to oral glucocorticoids (e.g., prednisone, dexamethasone). It effectively alleviates intestinal inflammation, relieves symptoms such as abdominal pain and diarrhea, helps patients through acute exacerbations, and lays the foundation for subsequent maintenance therapy. Clinically, this dose is usually administered intramuscularly, with frequency adjusted according to disease severity. It may be given once daily during acute flares and gradually tapered to a maintenance dose after symptom relief.

Ulcerative Colitis:Similar to Crohn's disease, ulcerative colitis is a chronic inflammatory bowel disease primarily limited to the mucosa and submucosa of the colon and rectum, characterized by recurrent abdominal pain and mucopurulent bloody stools. It reduces congestion, edema, and erosion of the colorectal mucosa via anti-inflammatory and immunosuppressive effects, relieving diarrhea and hematochezia. It is suitable for patients unresponsive or intolerant to oral glucocorticoids. Compared with exogenous glucocorticoids, it reduces adverse reactions such as gastrointestinal irritation, elevated blood glucose, and osteoporosis, improving patient treatment adherence.

Rheumatoid Arthritis:Rheumatoid arthritis is an autoimmune disease marked by erosive, symmetric polyarthritis affecting the synovium. Long-term progression can lead to joint deformity and loss of function. It is used for acute flares of rheumatoid arthritis. By stimulating endogenous cortisol secretion, it inhibits synovial inflammation, reduces joint swelling, pain, and stiffness, and slows joint damage. For patients intolerant to oral glucocorticoids, this dose can serve as short-term replacement therapy to control acute inflammation, alongside long-term management with antirheumatic drugs.

Osteoarthritis:Osteoarthritis is a degenerative joint disease characterized by articular cartilage wear and osteophyte formation, with clinical symptoms including joint pain, stiffness, and limited mobility, often accompanied by joint inflammation. It relieves joint inflammation and reduces pain and stiffness, especially in patients with mild to moderate inflammation. By avoiding direct exogenous glucocorticoid use, it causes less damage to articular cartilage and offers improved safety. It is mostly used for short-term relief of acute inflammatory symptoms, combined with physical therapy and nutritional supplementation for comprehensive management.

Acute Rheumatic Fever:Acute rheumatic fever is an autoimmune disorder triggered by group A beta-hemolytic streptococcal infection, primarily affecting the heart, joints, skin, and other tissues. Clinical manifestations include red, swollen, hot, and painful joints, palpitations, and skin rashes. Tetracosactide 250 mcg mitigates systemic inflammation and relieves joint pain and rashes through immunosuppressive and anti-inflammatory effects. It is especially useful for patients intolerant to oral glucocorticoids, effectively controlling disease progression and reducing complications such as heart valve damage.

Bell's Palsy:Bell's palsy is an acute peripheral facial nerve paralysis with incompletely understood etiology, possibly linked to viral infection and autoimmune responses. Clinical features include unilateral facial muscle weakness, drooping mouth, and difficulty closing the eye.

It improves facial nerve blood circulation and promotes neurological recovery by reducing inflammation and nerve edema. It is indicated for the acute phase of Bell's palsy, effectively shortening the disease course and improving recovery rates, particularly in patients with contraindications to oral glucocorticoids.

Choroiditis:Choroiditis is a form of uveitis affecting the choroid, mostly caused by autoimmune reactions and infection. Symptoms include vision loss, eye pain, photophobia, and floaters, which may lead to blindness in severe cases. It reduces choroidal inflammation, relieves ocular discomfort, and preserves vision via immunosuppressive and anti-inflammatory effects. It is suitable for choroiditis patients intolerant to oral glucocorticoids, effectively controlling inflammation and preventing complications.